DMD

12 registered clinical trials studyying DMD — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients NCT07287189	Satellos Bioscience, Inc.	Phase 2
Recruiting	A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne M NCT07058662	Belief BioMed (Beijing) Co., Ltd	Phase 1 / Phase 2
Recruiting	ML-Based Multi-Sensor Fall Risk Screening in DMD NCT07015632	Seoul National University Hospital	—
Recruiting	Vasodilator and Exercise Study for DMD (VASO-REx) NCT06290713	University of Florida	Phase 2
Recruiting	NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD) NCT05996003	NS Pharma, Inc.	Phase 2
Active Not Recruiting	Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 NCT06244082	Avidity Biosciences, Inc.	Phase 2
Recruiting	Defining Outcome Measures for Behavioural and Emotional Problems in Dystrophinopathies NCT06581887	University College, London	—
Recruiting	Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Init NCT05635266	Sanguine Biosciences	—
Withdrawn	Multi-center Clinical Study on the Diagnosis and Treatment Management of Rare Neurological Disease in Children NCT03649919	Children's Hospital of Fudan University	—
Recruiting	Swiss Registry for Neuromuscular Disorders NCT05102916	University of Bern	—
Completed	Constipation and Gut Transit in DMD Patients NCT01890616	Children's Hospital Medical Center, Cincinnati	—
Approved For Marketing	The Expanded Access Use of Viltolarsen in Duchenne Muscular Dystrophy With Confirmed Exon 53 Amenable Mutation NCT04337112	NS Pharma, Inc.	—